Group visits may help underserved kids with diabetes
NCT ID NCT05431686
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether shared medical appointments (group visits) could help underserved children aged 8–12 with poorly controlled type 1 diabetes. The 14 participants attended group visits every 3 months for a year, focusing on using diabetes technology and improving blood sugar control. The study measured how many families agreed to join, how often they attended, and their satisfaction with the program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
shared medical appointments (behavioral intervention)
What this could lead to
If successful, this approach could offer a practical way to help high-risk children with type 1 diabetes better manage their condition and use glucose monitors.
What could go wrong
This is a very small pilot study with only 14 participants, so results may not apply to larger groups. It tests feasibility, not effectiveness, and may not lead to clear health improvements.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States